Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Heart and Vessels

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00380-011-0141-5PMID 21505854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urocortin modulates dopaminergic neuronal survival via inhibition of glycogen synthase kinase-3β and histone deacetylase.

  2011cited by this paper
• Protective effect of urocortin on 1-methyl-4-phenylpyridinium-induced dopaminergic neuronal death

  2010cited by this paper
• The use of H1-receptor antagonists and left ventricular remodeling in patients on chronic hemodialysis

  2010cited by this paper
• Circulating levels of stress associated peptide Urocortin in heart failure patients.

  2010cited by this paper
• Enhanced expression of the ubiquitin-proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an immunohistochemical study with special reference to oxidative stress

  2010cited by this paper
• Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3beta signaling pathway.

  2010cited by this paper
• The nonpeptide AVE0991 attenuates myocardial hypertrophy as induced by angiotensin II through downregulation of transforming growth factor-β1/Smad2 expression

  2010cited by this paper
• Unique and Overlapping Functions of GSK-3 Isoforms in Cell Differentiation and Proliferation and Cardiovascular Development*

  2009cited by this paper
• GSK3 inhibitors and disease.

  2009cited by this paper
• Plasma Urocortin 1 in Human Heart Failure

  2009cited by this paper
• Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation.

  2008cited by this paper
• Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis

  2008cited by this paper
• Glycogen Synthase Kinase-3β—Actively Inhibiting Hypertrophy

  2007cited by this paper
• Glycogen synthase kinase-3beta -- actively inhibiting hypertrophy.

  2007cited by this paper
• Urocortin Modulates Inflammatory Response and Neurotoxicity Induced by Microglial Activation1

  2007cited by this paper
• Thyroid Hormone Stimulates Protein Synthesis in the Cardiomyocyte by Activating the Akt-mTOR and p70S6K Pathways*

  2006cited by this paper
• Protein kinase cascades in the regulation of cardiac hypertrophy.

  2005cited by this paper
• Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes.

  2005cited by this paper
• Hypertrophic effects of urocortin homologous peptides are mediated via activation of the Akt pathway.

  2005influential reference
• Urocortin: advancing the neurohumoral hypothesis of heart failure.

  2005cited by this paper
• CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators

  2004cited by this paper
• GSK3 inhibitors: development and therapeutic potential

  2004cited by this paper
• Plasma urocortin in human systolic heart failure.

  2004cited by this paper
• Urocortins: putative role in cardiovascular disease.

  2004cited by this paper
• Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth

  2003influential reference
• PI 3-kinase-Akt-p70 S6 kinase in hypertrophic responses to leukemia inhibitory factor in cardiac myocytes.

  2003cited by this paper
• Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo

  2002cited by this paper
• Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytes.

  2002cited by this paper
• Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.

  2002cited by this paper
• The CRF peptide family and their receptors: yet more partners discovered.

  2002cited by this paper
• Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.

  2002cited by this paper
• Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death.

  2002cited by this paper
• Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

  2002cited by this paper
• Demonstration of Direct Effects of Growth Hormone on Neonatal Cardiomyocytes*

  2001cited by this paper
• Tumour necrosis factor-alpha activation of protein kinase B in WEHI-164 cells is accompanied by increased phosphorylation of Ser473, but not Thr308.

  2001cited by this paper
• The conserved phosphoinositide 3‐kinase pathway determines heart size in mice

  2000cited by this paper
• Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart.

  2000cited by this paper
• Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes.

  1998cited by this paper

• The glycogen synthase kinase-3 in the regulation of ion channels and cellular carriers.

  2019cites this paper
• Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials.

  2019cites this paper
• Corticotropin-releasing factor (CRF) system localization in human fetal heart.

  2016cites this paper
• Down-Regulation of the Na+,Cl- Coupled Creatine Transporter CreaT (SLC6A8) by Glycogen Synthase Kinase GSK3ß

  2016cites this paper
• Up-Regulation of the Large-Conductance Ca2+-Activated K+ Channel by Glycogen Synthase Kinase GSK3β

  2016cites this paper
• Corticotropin-releasing factor (CRF) system localization in human fetal heart

  2016cites this paper
• The Urocortin System: A Novel Bone Regulatory Triad, Working In Opposition to RANKL/RANK/OPG

  2015cites this paper
• NFAT transcription factor regulation by urocortin II in cardiac myocytes and heart failure.

  2014cites this paper
• SGK1 is involved in cardioprotection of urocortin-1 against hypoxia/reoxygenation in cardiomyocytes.

  2014cites this paper
• The Azaindole Framework in the Design of Kinase Inhibitors

  2014cites this paper
• Novel Management of Heart Failure

  2013cites this paper
• Sgk1-Dependent Stimulation of Cardiac Na+/H+ Exchanger Nhe1 by Dexamethasone

  2013cites this paper
• Regulation and Roles of Urocortins in the Vascular System

  2012cites this paper
• Sgk1 sensitivity of Na+/H+ exchanger activity and cardiac remodeling following pressure overload

  2012cites this paper
• Effect of ouabain on myocardial ultrastructure and cytoskeleton during the development of ventricular hypertrophy

  2011cites this paper